These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1941 related articles for article (PubMed ID: 8823492)

  • 41. 1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-(methylamino)carbonylhydrazine (101M): a novel sulfonylhydrazine prodrug with broad-spectrum antineoplastic activity.
    Finch RA; Shyam K; Penketh PG; Sartorelli AC
    Cancer Res; 2001 Apr; 61(7):3033-8. PubMed ID: 11306484
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo.
    Elliott WL; Roberts BJ; Howard CT; Leopold WR
    Cancer Res; 1994 Aug; 54(16):4412-8. PubMed ID: 8044790
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro and in vivo circumvention of multidrug resistance by Servier 9788, a novel triazinoaminopiperidine derivative.
    Pierré A; Dunn TA; Kraus-Berthier L; Léonce S; Saint-Dizier D; Régnier G; Dhainaut A; Berlion M; Bizzari JP; Atassi G
    Invest New Drugs; 1992 Aug; 10(3):137-48. PubMed ID: 1428723
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antitumor activity of macromomycin B (NSC 170105) against murine leukemias, melanoma, and lung carcinoma.
    Lippman MM; Laster WR; Abbott BJ; Venditti J; Baratta M
    Cancer Res; 1975 Apr; 35(4):939-45. PubMed ID: 1116151
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of Corynebacterium parvum alone and in combination with adriamycin in experimental tumor systems.
    Houchens DP; Johnson RK; Ovejera A; Gaston MR; Goldin A
    Cancer Treat Rep; 1976 Jul; 60(7):823-8. PubMed ID: 1009517
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Models of preclinical studies of anthracyclines].
    Fizames C
    Pathol Biol (Paris); 1987 Jan; 35(1):41-8. PubMed ID: 3550611
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activity of the pyrazoloacridines against multidrug-resistant tumor cells.
    Sebolt J; Havlick M; Hamelehle K; Nelson J; Leopold W; Jackson R
    Cancer Chemother Pharmacol; 1989; 24(4):219-24. PubMed ID: 2752501
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Potentiation of antitumor and antimetastatic activities of adriamycin by a novel N-alkylated dihydropyridine, AC394, and its enantiomers in colon cancer-bearing mice.
    Ohishi K; Morinaga Y; Ohsumi K; Nakagawa R; Suga Y; Tsuji T; Akiyama Y; Tsuruo T
    Cancer Chemother Pharmacol; 1996; 38(5):446-52. PubMed ID: 8765438
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antitumor activity of a derivative of mitomycin, 7-N-[2-[[2-(gamma-L-glutamylamino)ethyl]dithio]ethyl]mitomycin C (KW-2149), against murine and human tumors and a mitomycin C-resistant tumor in vitro and in vivo.
    Tsuruo T; Sudo Y; Asami N; Inaba M; Morimoto M
    Cancer Chemother Pharmacol; 1990; 27(2):89-93. PubMed ID: 2123421
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preclinical antitumor activity of a soluble etoposide analog, BMY-40481-30.
    Rose WC; Basler GA; Trail PA; Saulnier M; Crosswell AR; Casazza AM
    Invest New Drugs; 1990; 8 Suppl 1():S25-32. PubMed ID: 2380014
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antitumor effect of CPT-11, a new derivative of camptothecin, against pleiotropic drug-resistant tumors in vitro and in vivo.
    Tsuruo T; Matsuzaki T; Matsushita M; Saito H; Yokokura T
    Cancer Chemother Pharmacol; 1988; 21(1):71-4. PubMed ID: 3342468
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antitumor activity of mitoxantrone against murine experimental tumors: comparative analysis against various antitumor antibiotics.
    Fujimoto S; Ogawa M
    Cancer Chemother Pharmacol; 1982; 8(2):157-62. PubMed ID: 7105379
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antitumor activity of intoplicine (RP 60475, NSC 645008), a new benzo-pyrido-indole: evaluation against solid tumors and leukemias in mice.
    Bissery MC; Nguyen CH; Bisagni E; Vrignaud P; Lavelle F
    Invest New Drugs; 1993 Nov; 11(4):263-77. PubMed ID: 8157469
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and biological evaluation of 6-(9-hydroxy-5-methyl (and 5,6-dimethyl)-6H-pyrido[4,3-b]carbazol-1-yl)picolinic amides as new olivacine derivatives.
    Landras C; Jasztold-Howorko R; Pierré A; Léonce S; Guilbaud N; Kraus-Berthier L; Guillonneau C; Rolland Y; Atassi G; Bisagni E
    Chem Pharm Bull (Tokyo); 1996 Nov; 44(11):2169-72. PubMed ID: 8945783
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of quinidine effect on the antitumor activity of adriamycin and mitoxantrone in adriamycin-sensitive and -resistant P388 leukemia cells.
    Parekh H; Chitnis M
    Sel Cancer Ther; 1990; 6(2):93-102. PubMed ID: 2367755
    [TBL] [Abstract][Full Text] [Related]  

  • 56. FK317: a novel substituted dihydrobenzoxazine with potent antitumor activity which does not induce vascular leak syndrome.
    Naoe Y; Inami M; Matsumoto S; Nishigaki F; Tsujimoto S; Kawamura I; Miyayasu K; Manda T; Shimomura K
    Cancer Chemother Pharmacol; 1998; 42(1):31-6. PubMed ID: 9619755
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antitumor activities of a novel 9-aminoanthracycline (SM-5887) against mouse experimental tumors and human tumor xenografts.
    Morisada S; Yanagi Y; Noguchi T; Kashiwazaki Y; Fukui M
    Jpn J Cancer Res; 1989 Jan; 80(1):69-76. PubMed ID: 2496061
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antitumor activity of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-2- isopropyl-1,3-dioxolane]platinum(II), a new platinum analogue, as an anticancer agent.
    Kim DK; Kim HT; Cho YB; Tai JH; Ahn JS; Kim TS; Kim KH; Hong WS
    Cancer Chemother Pharmacol; 1995; 35(5):441-5. PubMed ID: 7850928
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of homoharringtonine on the viability of murine leukemia P388 cells resistant to either adriamycin, vincristine, or 1-beta-D-arabinofuranosylcytosine.
    Wilkoff LJ; Dulmadge DA; Laster WR; Griswold DP
    Cancer Chemother Pharmacol; 1989; 23(3):145-50. PubMed ID: 2924372
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preclinical antitumor activity of batracylin (NSC 320846).
    Plowman J; Paull KD; Atassi G; Harrison SD; Dykes DJ; Kabbe HJ; Narayanan VL; Yoder OC
    Invest New Drugs; 1988 Sep; 6(3):147-53. PubMed ID: 3192381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 98.